Sex Differences in Morphine Analgesia: An Experimental Study in Healthy Volunteers

BackgroundAnimal and human studies indicate the existence of important sex-related differences in opioid-mediated behavior. In this study the authors examined the influence of morphine on experimentally induced pain in healthy male and female volunteers. MethodsYoung healthy men and women (10 of each sex) received intravenous morphine (bolus 0.1-mg/kg dose followed by an infusion of 0.030 mg · kg−1 · h−1 for 1 h). Pain threshold and pain tolerance in response to a gradual increase in transcutaneous electrical stimulation, as well as plasma concentrations of morphine and its major metabolites (morphine-6-glucuronide and morphine-3-glucuronide) were determined at regular intervals up to 7 h after the start of morphine infusion. A population pharmacodynamic model was used to analyze the morphine-induced changes in stimulus intensity. The improvement of the model fits by inclusion of covariates (sex, age, weight, lean body mass) was tested for significance. The model is characterized by baseline current, a rate constant for equilibrium between plasma and effect-site morphine concentrations (ke0), and analgesic potency (AC50, or the morphine concentration causing a 100% increase in stimulus intensity for response). ResultsThe inclusion of the covariates age, weight, and lean body mass did not improve the model fits for any of the model parameters. For both pain threshold and tolerance, a significant dependency on sex was observed for the parameters ke0 (pain threshold: 0.0070 ± 0.0013 (± SE) min−1 in men vs. 0.0030 ± 0.0005 min−1 in women; pain tolerance: 0.0073 ± 0.0012 min−1 in men vs. 0.0024 ± 0.0005 min−1 in women) and AC50 (pain threshold: 71.2 ± 10.5 nm in men vs. 41.7 ± 8.4 nm in women; pain tolerance: 76.5 ± 7.4 nm in men vs. 32.9 ± 7.9 nm in women). Baseline currents were similar for both sexes: 21.4 ± 1.6 mA for pain threshold and 39.1 ± 2.3 mA for pain tolerance. Concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide did not differ between men and women. ConclusionsThese data show sex differences in morphine analgesia, with greater morphine potency but slower speed of onset and offset in women. The data are in agreement with observations of sex differences in morphine-induced respiratory depression and may explain higher postoperative opioid consumption in men relative to women.

[1]  A. Dahan,et al.  Gender Differences in Opioid-mediated Analgesia: Animal and Human Studies , 2000, Anesthesiology.

[2]  S. Aebi,et al.  Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers. , 2000, British journal of anaesthesia.

[3]  A. Dahan,et al.  Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop. , 2000, Anesthesiology.

[4]  J. Mogil,et al.  Sex differences in supraspinal morphine analgesia are dependent on genotype. , 1999, The Journal of pharmacology and experimental therapeutics.

[5]  G. Hobbs,et al.  Persistently high plasma morphine-6-glucuronide levels despite decreased hourly patient-controlled analgesia morphine use after single-dose diclofenac: potential for opioid-related toxicity. , 1999, Anesthesia and analgesia.

[6]  J. Mogil,et al.  Sex differences in opioid analgesia , 1999 .

[7]  J. Levine,et al.  Does opioid analgesia show a gender preference for females , 1999 .

[8]  G. Pasternak,et al.  Retention of heroin and morphine–6β–glucuronide analgesia in a new line of mice lacking exon 1 of MOR–1 , 1999, Nature Neuroscience.

[9]  H. Lemmens,et al.  Population Pharmacodynamics and Pharmacokinetics of Remifentanil as a Supplement to Nitrous Oxide Anesthesia for Elective Abdominal Surgery , 1998, Anesthesiology.

[10]  J. Walsh,et al.  INTRAVENOUS AND INHALED MORPHINE PHARMACOKINETICS AND PHARMACODYNAMICS AS MEASURED BY PUPILLOMETRY , 1998 .

[11]  M. Morgan,et al.  Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats , 1998, Brain Research.

[12]  J. Carmody,et al.  Experimental Pain in Healthy Human Subjects: Gender Differences in Nociception and in Response to Ibuprofen , 1998, Anesthesia and analgesia.

[13]  A. Dahan,et al.  Sex‐related Differences in the Influence of Morphine on Ventilatory Control in Humans , 1998, Anesthesiology.

[14]  M. Hammarlund-Udenaes,et al.  Delayed antinociceptive effect following morphine-6-glucuronide administration in the rat – pharmacokinetic/pharmacodynamic modelling , 1998, Pain.

[15]  A. Luks,et al.  Opioid-induced analgesia in neonatal dogs: pharmacodynamic differences between morphine and fentanyl. , 1998, The Journal of pharmacology and experimental therapeutics.

[16]  G. Kobal,et al.  Lack of Analgesic Activity of Morphine‐6‐glucuronide after Short‐term Intravenous Administration in Healthy Volunteers , 1997, Anesthesiology.

[17]  A. Dahan,et al.  Influence of Acute Pain Induced by Activation of Cutaneous Nociceptors on Ventilatory Control , 1997, Anesthesiology.

[18]  T. Cicero,et al.  Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. , 1997, The Journal of pharmacology and experimental therapeutics.

[19]  R. Pacifici,et al.  Simultaneous determination of heroin 6-monoacetylmorphine, morphine, and its glucuronides by liquid chromatography--atmospheric pressure ionspray-mass spectrometry. , 1997, Journal of analytical toxicology.

[20]  U. Lendahl Transgenic analysis of central nervous system development and regeneration , 1997, Acta anaesthesiologica Scandinavica. Supplementum.

[21]  L. Christrup Morphine metabolites , 1997, Acta anaesthesiologica Scandinavica.

[22]  Thomas W. Schnider,et al.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development , 1997 .

[23]  T. Cicero,et al.  Gender-related differences in the antinociceptive properties of morphine. , 1996, The Journal of pharmacology and experimental therapeutics.

[24]  J. Levine,et al.  Kappa–opioids produce significantly greater analgesia in women than in men , 1996, Nature Medicine.

[25]  K. Voigt,et al.  Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat. , 1996, The Journal of pharmacology and experimental therapeutics.

[26]  J. Levine,et al.  Gender difference in analgesic response to the kappa-opioid pentazocine , 1996, Neuroscience Letters.

[27]  Maree T. Smith,et al.  Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat , 1995, Pain.

[28]  H. Thaler,et al.  The metabolite morphine‐6‐glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function , 1992, Clinical pharmacology and therapeutics.

[29]  T. Hedner,et al.  Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat , 1992, Pain.

[30]  F. M. Levine,et al.  The effects of experimenter gender on pain report in male and female subjects , 1991, Pain.

[31]  James C. Scott,et al.  Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. , 1991, Anesthesiology.

[32]  G. Pasternak,et al.  Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. , 1989, The Journal of pharmacology and experimental therapeutics.

[33]  G. Aherne,et al.  EXPLANATION FOR POTENCY OF REPEATED ORAL DOSES OF MORPHINE? , 1987, The Lancet.

[34]  D R Stanski,et al.  EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. , 1985, Anesthesiology.

[35]  L B Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. , 1980, Clinical pharmacology and therapeutics.

[36]  J. Durnin,et al.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years , 1974, British Journal of Nutrition.

[37]  F. N. David,et al.  LINEAR STATISTICAL INFERENCE AND ITS APPLICATION , 1967 .

[38]  Hugh Ae,et al.  BROAD-SPECTRUM REDEFINED. , 1963 .